Latest Drugwonks' Blog
Consider the Federal Register notice announcing the August 14/15 meeting of the FDA's Risk Communications advisory committee:
"The committee will meet for presentations and discussion of the scientific basis for translating principles of risk communication into practice in situations of emerging and uncertain risk."
And this is the committee that's mandated to create clear ways to discuss risk communications (or as it's cool to say in DC "Plain English").
I think it was Albert Einstein who said something along the lines of, "If you can't explain a complicated topic in a simple way -- then you don't really understand it."
What happens is the meeting of the Patient-Centric Health Leadership Forum.
This new report shares the cutting edge thinking of the folks mentioned above along with other similarly talented leaders. And the key phrase is patient-centric.
The report can be found at the top of this page or here, the first item under "reports."
A worthwhile and important read.
Experimental cures are often the last hope for dying patients in the U. K. health system. Thanks to the British government, however, many sick Britons will soon have their last hopes dashed.
Why? Pharmaceutical companies from around the world have been scaling back clinical research in the
Read more about this distressing development here:
British system discourages availability of new drugs
See for yourself:
Shaedegg Video Interview
And let us know what you think.
Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.
